Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -1.72% | +1.42% | +72.73% |
12/04 | Transcript : Generation Bio Co. - Special Call | |
07/03 | Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating | MT |
Sales 2024 * | 5.59M 467M | Sales 2025 * | 4.77M 398M | Capitalization | 189M 15.82B |
---|---|---|---|---|---|
Net income 2024 * | -86M -7.18B | Net income 2025 * | -97M -8.1B | EV / Sales 2024 * | 6.35 x |
Net cash position 2024 * | 154M 12.86B | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 39.7 x |
P/E ratio 2024 * |
-2.04
x | P/E ratio 2025 * |
-2.19
x | Employees | 174 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.51% |
Latest transcript on Generation Bio Co.
1 day | -1.72% | ||
1 week | +1.42% | ||
Current month | -29.98% | ||
1 month | -29.98% | ||
3 months | +50.00% | ||
6 months | +211.71% | ||
Current year | +72.73% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 01/17/01 | |
Matthew Norkunas
DFI | Director of Finance/CFO | 46 | 22/20/22 |
Antoinette Paone
COO | Chief Operating Officer | 46 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 01/18/01 |
Director/Board Member | 76 | 01/17/01 | |
Jason Rhodes
FOU | Founder | 54 | 01/16/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 2.85 | -1.72% | 808,985 |
26/24/26 | 2.9 | -3.65% | 92,075 |
25/24/25 | 3.01 | +0.67% | 156,786 |
24/24/24 | 2.99 | -8.28% | 114,491 |
23/24/23 | 3.26 | +16.01% | 213,942 |
Delayed Quote Nasdaq, April 30, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.73% | 189M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.63% | 22.18B | |
-16.67% | 21.2B | |
-8.68% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- GBIO Stock